Detalhe da pesquisa
1.
Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease.
Virol J
; 21(1): 68, 2024 03 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38509536
2.
Short-term inhibition of SARS-CoV-2 by hydrogen peroxide in persistent nasopharyngeal carriers.
J Med Virol
; 93(3): 1766-1769, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32881014
3.
Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine.
Clin Infect Dis
; 73(6): e1402-e1403, 2021 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33693610
4.
Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects.
Hum Vaccin Immunother
; 18(5): 2060018, 2022 11 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35511791
5.
One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG.
J Infect
; 83(2): 237-279, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34052240
6.
Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugs: A retrospective study.
Medicine (Baltimore)
; 96(7): e5728, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-28207500
7.
Persistence of Long-COVID symptoms in a heterogenous prospective cohort.
J Infect
; 84(5): 722-746, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35077770
8.
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study.
J Infect
; 82(5): e28-e30, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33545166
9.
cART durability and causes for treatment switching or discontinuation in HIV-positive patients older than 50 years of age.
J Acquir Immune Defic Syndr
; 55(2): e12-4, 2010 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-20859084